Neogen Corporation
$9.63
▲
0.21%
2026-04-21 08:22:01
www.neogen.com
NMS: NEOG
Explore Neogen Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$2.08 B
Current Price
$9.63
52W High / Low
$11.43 / $4.32
Stock P/E
—
Book Value
$9.68
Dividend Yield
—
ROCE
-0.05%
ROE
-25.57%
Face Value
—
EPS
$-2.8
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
2,974
Beta
1.97
Debt / Equity
37.82
Current Ratio
3.92
Quick Ratio
2.22
Forward P/E
31.75
Price / Sales
2.36
Enterprise Value
$2.69 B
EV / EBITDA
33.05
EV / Revenue
3.08
Rating
Buy
Target Price
$12
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | NeuroOne Medical Technologies Corporation | $4.98 | — | $40.89 M | — | -49.83% | -1.46% | $6.96 / $3 | $0.13 |
| 2. | IRADIMED CORPORATION | $92.93 | 52.96 | $1.19 B | 0.76% | 26.52% | 24.78% | $107.9 / $50 | $7.4 |
| 3. | Lumexa Imaging Holdings, Inc. | $9.65 | — | $928.42 M | — | 1.69% | -12.6% | $19.45 / $7.23 | $6.1 |
| 4. | InfuSystem Holdings, Inc. | $10.79 | 32.21 | $213.43 M | — | 14.83% | 11.54% | $11.04 / $4.66 | $2.84 |
| 5. | Aethlon Medical, Inc. | $2.39 | — | $3.67 M | — | -171.08% | -2.09% | $35.2 / $1.36 | $6.9 |
| 6. | Smith & Nephew plc | $32.71 | 22.84 | $14.01 B | 2.29% | 9.67% | 11.84% | $1,441.5 / $960.8 | $6.22 |
| 7. | Owlet, Inc. | $5.82 | — | $163.61 M | — | -19.96% | -8.02% | $16.94 / $3.08 | $0.71 |
Quarterly Results
Figures shown in M / B
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|---|
| Sales | 211.2 M | 224.69 M | 209.19 M | 225.46 M | 221 M | — |
| Operating Profit | -3.3 M | -5.38 M | -16.09 M | -13.25 M | 5.4 M | — |
| Net Profit | -17 M | -15.92 M | 36.34 M | -612.2 M | -10.9 M | — |
| EPS in Rs | -0.08 | -0.07 | 0.17 | -2.81 | -0.05 | -2.1 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 894.66 M | 924.22 M | 822.45 M | 527.16 M |
| Operating Profit | -1.68 M | 58.66 M | 37.52 M | 58.62 M |
| Net Profit | -1.09 B | -9.42 M | -22.87 M | 48.31 M |
| EPS in Rs | -5.02 | -0.04 | -0.11 | 0.22 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 3.44 B | 4.55 B | 4.55 B | 992.93 M |
| Total Liabilities | 1.37 B | 1.4 B | 1.42 B | 105.56 M |
| Equity | 2.07 B | 3.14 B | 3.13 B | 887.37 M |
| Current Assets | 576.94 M | 589.23 M | 585.93 M | 626.8 M |
| Current Liabilities | 174.01 M | 154.32 M | 145.47 M | 77.84 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 58.24 M | 35.26 M | 41.03 M | 68.04 M |
| Investing CF | -99.19 M | -29.31 M | 201.04 M | -97.23 M |
| Financing CF | -1.6 M | 1.92 M | -118.08 M | 6.81 M |
| Free CF | -46.35 M | -76.16 M | -24.73 M | 43.61 M |
| Capex | -104.59 M | -111.42 M | -65.76 M | -24.43 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | -3.2% | 12.37% | 56.01% | — |
| Earnings Growth % | -11491.59% | 58.81% | -147.34% | — |
| Profit Margin % | -122.06% | -1.02% | -2.78% | 9.16% |
| Operating Margin % | -0.19% | 6.35% | 4.56% | 11.12% |
| Gross Margin % | 47.1% | 50.19% | 49.36% | 46.1% |
| EBITDA Margin % | -104.6% | 19.51% | 15.12% | 16.01% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2021-06-07 | 1:2 |